| scholarly article | Q13442814 |
| P2093 | author name string | McCune WJ | |
| Gebarski S | |||
| Aisen A | |||
| MacGuire A | |||
| P2860 | cites work | Nuclear magnetic resonance techniques in medicine | Q36632780 |
| Clinical NMR imaging of the brain: 140 cases | Q41457200 | ||
| Computed tomography of systemic lupus erythematosus | Q43837094 | ||
| The validity of criteria for the evaluation of cerebral atrophy by computed tomography | Q48453406 | ||
| Brain scan findings in central nervous system involvement by lupus erythematosus | Q48502475 | ||
| P433 | issue | 2 | |
| P921 | main subject | neuropsychiatric systemic lupus erythematosus | Q9358981 |
| P304 | page(s) | 159-166 | |
| P577 | publication date | 1988-02-01 | |
| P1433 | published in | Arthritis & Rheumatology | Q4797636 |
| P1476 | title | Identification of brain lesions in neuropsychiatric systemic lupus erythematosus by magnetic resonance scanning | |
| P478 | volume | 31 |
| Q71814762 | 18FDG PET and acetazolamide-enhanced99mTc-HMPAO SPET in systemic lupus erythematosus |
| Q33881567 | A Case of Mania in a Patient with Systemic Lupus Erythematosus: Can Its Inflammatory Pathogenesis be Applied to Primary Mood Disorders? |
| Q72113307 | Abnormalities of magnetic resonance imaging of the central nervous system in patients with systemic lupus erythematosus correlate with disease severity |
| Q49026833 | Accuracy of 133-xenon regional cerebral blood flow and quantitative electroencephalography in systemic lupus erythematosus |
| Q34478835 | Brain MRI in patients with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus |
| Q34307190 | Brain single-photon emission tomography with 99mTc-HMPAO in neuropsychiatric systemic lupus erythematosus: relations with EEG and MRI findings and clinical manifestations |
| Q33584052 | Central nervous system systemic lupus erythematosus mimicking progressive multifocal leucoencephalopathy |
| Q48724943 | Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE: a population-based study |
| Q48491099 | Cerebral magnetic resonance imaging in patients with or without antiphospholipid antibodies |
| Q33567067 | Controversies in lupus: nervous system involvement |
| Q89282128 | Correlation of neurocognitive function and brain lesion load on magnetic resonance imaging in systemic lupus erythematosus |
| Q33547420 | Cortical thickness and subcortical gray matter reductions in neuropsychiatric systemic lupus erythematosus |
| Q38660157 | Current concepts of neuropsychiatric systemic lupus erythematosus (NP-SLE) |
| Q44921329 | Dementia with leukoencephalopathy in systemic lupus erythematosus |
| Q74385636 | Diffusion-weighted echo-planar MR imaging of CNS involvement in systemic lupus erythematosus |
| Q48299120 | Discrepancy between regional cerebral blood flow and glucose metabolism of the brain in systemic lupus erythematosus patients with normal brain magnetic resonance imaging findings |
| Q33592040 | Fluctuating cognitive abnormalities and cerebral glucose metabolism in neuropsychiatric systemic lupus erythematosus |
| Q44698496 | In vivo proton magnetic resonance spectroscopy (MRS) and single photon emission computerized tomography (SPECT) in systemic lupus erythematosus (SLE). |
| Q60046879 | Laboratory and Neuroimaging Biomarkers in Neuropsychiatric Systemic Lupus Erythematosus: Where Do We Stand, Where To Go? |
| Q40633667 | Laminar cortical necrosis in central nervous system lupus: sequential changes in MR images |
| Q40406766 | MRI and 2D-CSI MR spectroscopy of the brain in the evaluation of patients with acute onset of neuropsychiatric systemic lupus erythematosus |
| Q36651573 | Magnetic resonance imaging and brain histopathology in neuropsychiatric systemic lupus erythematosus. |
| Q46909297 | Magnetic resonance imaging of the brain in neuropsychiatric systemic lupus erythematosus |
| Q44436037 | Markers of acute neuropsychiatric systemic lupus erythematosus: a multidisciplinary evaluation |
| Q33908254 | Naja naja atra Venom Protects against Manifestations of Systemic Lupus Erythematosus in MRL/lpr Mice |
| Q40929944 | Nervous system lupus: pathogenesis and rationale for therapy |
| Q71459017 | Neuroimaging in chronic fatigue syndrome |
| Q33753228 | Neuroimaging in neuropsychiatric systemic lupus erythematosus |
| Q40149699 | Neurometabolic changes in normal white matter may predict appearance of hyperintense lesions in systemic lupus erythematosus |
| Q48172708 | Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement |
| Q40469520 | Neuropsychiatric Manifestations of Systemic Lupus Erythematosus |
| Q38856432 | Neuropsychiatric manifestations in a consecutive cohort of systemic lupus erythematosus; a single center study |
| Q61755946 | PET/CT and PET/MRI in Neurology: Infection/Inflammation |
| Q33292539 | Posterior reversible encephalopathy syndrome: another manifestation of CNS SLE? |
| Q73251573 | Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus |
| Q48412472 | Quantitative electroencephalography. A new approach to the diagnosis of cerebral dysfunction in systemic lupus erythematosus |
| Q30887271 | Quantitative magnetic resonance imaging in neuropsychiatric systemic lupus erythematosus. |
| Q35636738 | Raised monocyte chemotactic protein-1 (MCP-1)/CCL2 in cerebrospinal fluid of patients with neuropsychiatric lupus |
| Q40572101 | Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus |
| Q33733833 | Single photon emission computed tomography in systemic lupus erythematosus with psychiatric symptoms |
| Q48439095 | Structural and neurochemical markers of brain injury in the migraine diathesis of systemic lupus erythematosus |
| Q48866999 | Subacute cerebellar ataxia and atrophy developed in a young woman with systemic lupus erythematosus whose cerebrospinal fluid was positive for antineuronal cell antibody |
| Q36204062 | Systemic Lupus Erythematosus with Central Nervous System Involvement |
| Q41333508 | Systemic lupus erythematosus. Diagnosis and treatment |
| Q42932972 | Tract-based spatial statistics on diffusion tensor imaging in systemic lupus erythematosus reveals localized involvement of white matter tracts |
| Q33195490 | Value of MRI of the brain in patients with systemic lupus erythematosus and neurologic disturbance |
| Q75310693 | [MRI of central nervous system in a series of 58 systemic lupus erythematosus (SLE) patients with or without overt neuropsychiatric manifestations] |
Search more.